Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
BRAF mutation Solid Tumors | IND Approval | CN | 30 Jan 2023 | |
EGFR mutation Solid Tumors | IND Approval | CN | 30 Jan 2023 | |
KRAS G12C mutation Solid Tumors | IND Approval | CN | 30 Jan 2023 | |
KRAS G12D mutation Solid Tumors | IND Approval | CN | 30 Jan 2023 |